Skip to main content
. 2016 May 16;33(2):128–133. doi: 10.5114/ada.2016.59156

Table 2.

Correlation between the prevalence of the R501X mutation and AD development

R501X Control group Studied group OR* P-value
1 2 1–2
N % N %
Total 61 100.0 60 100.0 5.56 0.0706
Normal genotype 61 100.0 55 91.6
Heterozygotes 0 0.0 4 6.6
Homozygotes 0 0.0 1 1.6